Canada markets closed
  • S&P/TSX

    20,179.81
    +187.93 (+0.94%)
     
  • S&P 500

    4,280.15
    +72.88 (+1.73%)
     
  • DOW

    33,761.05
    +424.38 (+1.27%)
     
  • CAD/USD

    0.7830
    -0.0007 (-0.09%)
     
  • CRUDE OIL

    91.88
    -2.46 (-2.61%)
     
  • BTC-CAD

    30,847.48
    -225.45 (-0.73%)
     
  • CMC Crypto 200

    574.64
    +3.36 (+0.59%)
     
  • GOLD FUTURES

    1,818.90
    +11.70 (+0.65%)
     
  • RUSSELL 2000

    2,016.62
    +41.36 (+2.09%)
     
  • 10-Yr Bond

    2.8490
    -0.0390 (-1.35%)
     
  • NASDAQ

    13,047.19
    +267.27 (+2.09%)
     
  • VOLATILITY

    19.53
    -0.67 (-3.32%)
     
  • FTSE

    7,500.89
    +34.98 (+0.47%)
     
  • NIKKEI 225

    28,546.98
    +727.65 (+2.62%)
     
  • CAD/EUR

    0.7627
    +0.0039 (+0.51%)
     

Stocks in play: Neighbourly Pharmacy Inc.

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Announced its financial results for the 12-week period ended September 11, 2021. Revenue for the second quarter 2022 increased by 54.0% to $90.7 million, driven by the addition of 51 pharmacies over the prior four quarters. Adjusted EBITDA1 for the second quarter 2022 increased by 51.5% to $10.0 million, primarily due to the incremental profitability of pharmacies added to the Company's network. Net Loss for the second quarter 2022 was $3.4 million, an improvement of $0.5 million, or 12.4%. Neighbourly Pharmacy Inc. shares T.NBLY are trading down $0.01 at $31.28.

Read:

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting